Company Registration No. 12933915 (England and Wales)
CEEPHARM LTD
Unaudited accounts
for the year ended 30 April 2024
CEEPHARM LTD
Unaudited accounts
Contents
CEEPHARM LTD
Company Information
for the year ended 30 April 2024
Director
Chukwuma Christian Okeke
Company Number
12933915 (England and Wales)
Registered Office
198 TWYFORD AVENUE
PORTSMOUTH
PO2 8JE
ENGLAND
Accountants
K3 Accountants Limited
Barnwood
Trampers Lane
North Boarhunt
Hampshire
PO17 6DG
CEEPHARM LTD
Statement of financial position
as at 30 April 2024
Intangible assets
208,947
238,797
Tangible assets
3,823
3,852
Cash at bank and in hand
452,207
349,984
Creditors: amounts falling due within one year
(342,749)
(308,151)
Net current assets
363,823
174,420
Total assets less current liabilities
576,593
417,069
Creditors: amounts falling due after more than one year
(186,835)
(197,428)
Net assets
389,758
219,641
Called up share capital
1
1
Profit and loss account
389,757
219,640
Shareholders' funds
389,758
219,641
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 24 January 2025 and were signed on its behalf by
Chukwuma Christian Okeke
Director
Company Registration No. 12933915
CEEPHARM LTD
Notes to the Accounts
for the year ended 30 April 2024
CEEPHARM LTD is a private company, limited by shares, registered in England and Wales, registration number 12933915. The registered office is 198 TWYFORD AVENUE, PORTSMOUTH, PO2 8JE, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
20% on cost
Fixtures & fittings
20% on cost
Computer equipment
20% on cost
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Goodwill
Charge for the year
29,850
Goodwill is capitalised and is being amortised over its useful life of 10 years.
CEEPHARM LTD
Notes to the Accounts
for the year ended 30 April 2024
5
Tangible fixed assets
Motor vehicles
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At 1 May 2023
1,500
1,563
1,665
4,728
At 30 April 2024
1,500
1,563
2,664
5,727
At 1 May 2023
600
26
250
876
Charge for the year
300
312
416
1,028
At 30 April 2024
900
338
666
1,904
At 30 April 2024
600
1,225
1,998
3,823
At 30 April 2023
900
1,537
1,415
3,852
Amounts falling due within one year
Trade debtors
90,794
73,226
Other debtors
109,288
8,400
7
Creditors: amounts falling due within one year
2024
2023
Bank loans and overdrafts
29,845
28,692
Trade creditors
77,375
64,462
Taxes and social security
66,823
40,167
Loans from directors
114,091
139,500
Deferred income
(12,410)
(10,375)
8
Creditors: amounts falling due after more than one year
2024
2023
Bank loans
186,835
197,428
9
Average number of employees
During the year the average number of employees was 8 (2023: 6).